← Back to Search

Hypertension telemedicine curriculum for High Blood Pressure

N/A
Waitlist Available
Led By Tracy K Paul, MD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 12
Awards & highlights

Study Summary

This trial will test a health education curriculum delivered by Weill Cornell Medicine faculty, medical students, and NY-Presbyterian Hospital resident physicians to adults in an under-resourced community.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Number of Participants Virtually Attending the Health Education Seminars
Change in Participant's Rate of Completion of Weekly Blood Pressure Recordings
Change in Participant's Rate of Completion of Weekly Steps Recordings
+1 more
Secondary outcome measures
Change in Self-Reported Health Attitudes and Behaviors As Assessed by Survey.
Mean Change in Diastolic Blood Pressure Measurement.
Mean Change in Number of Daily Steps Measured by Pedometer.
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Hypertension telemedicine curriculumExperimental Treatment1 Intervention
All participants participate in the 12-week telemedicine curriculum. All participants will be asked to record their steps via pedometer and their blood pressure measurements via automatic blood pressure arm cuff.

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,054 Previous Clinical Trials
1,316,528 Total Patients Enrolled
Health Resources and Services Administration (HRSA)FED
84 Previous Clinical Trials
151,487 Total Patients Enrolled
Tracy K Paul, MDPrincipal InvestigatorWeill Cornell Medicine/NY Presbyterian Hospital

Media Library

Lifestyle Modification Webinars Focused on Hypertension Control Clinical Trial Eligibility Overview. Trial Name: NCT05062473 — N/A
High Blood Pressure Research Study Groups: Hypertension telemedicine curriculum
High Blood Pressure Clinical Trial 2023: Lifestyle Modification Webinars Focused on Hypertension Control Highlights & Side Effects. Trial Name: NCT05062473 — N/A
Lifestyle Modification Webinars Focused on Hypertension Control 2023 Treatment Timeline for Medical Study. Trial Name: NCT05062473 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are being monitored as part of this clinical research?

"Affirmative. Clinicaltrials.gov reveals that, since it was initially uploaded on October 4th 2021, this trial has been actively recruiting participants across 1 medical centre for a total of 40 patients."

Answered by AI

What are the hoped-for outcomes of this experiment?

"The clinical trial's primary endpoint evaluates the participants' satisfaction with their curriculum at 12 weeks. Secondary endpoints track changes in daily steps taken, as measured by a wrist pedometer, and systolic/diastolic blood pressure readings recorded using an automatic arm cuff. These measurements will be collected from baseline to week 12 of the study."

Answered by AI

Are patients currently allowed to register for this trial?

"Affirmative. The listing on clinicaltrials.gov demonstrates that this research is actively accepting participants, with 40 required from one site. This trial was first posted on October 4th 2021 and the information was last updated November 18th 2022."

Answered by AI
Recent research and studies
~0 spots leftby Apr 2025